Published in J Virol on October 01, 1990
Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sci U S A (1991) 3.18
The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J (1997) 2.10
Transmembrane domain of influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in polarized MDCK cells. J Virol (1996) 1.95
Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus. J Virol (1997) 1.87
Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J Virol (1995) 1.73
Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J (1992) 1.54
Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Respir Res (2009) 1.40
Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J Virol (2005) 1.36
Role of actin microfilaments in Black Creek Canal virus morphogenesis. J Virol (1998) 1.34
Assembly and polarized release of Punta Toro virus and effects of brefeldin A. J Virol (1991) 1.30
Targeted infection of endothelial cells by avian influenza virus A/FPV/Rostock/34 (H7N1) in chicken embryos. J Virol (2000) 1.23
Sendai virus assembly: M protein binds to viral glycoproteins in transit through the secretory pathway. J Virol (1993) 1.22
Polarized budding of measles virus is not determined by viral surface glycoproteins. J Virol (1998) 1.21
Polarized entry and release in epithelial cells of Black Creek Canal virus, a New World hantavirus. J Virol (1997) 1.17
Polarity of human parainfluenza virus type 3 infection in polarized human lung epithelial A549 cells: role of microfilament and microtubule. J Virol (2001) 1.09
Possible involvement of microtubule disruption in bipolar budding of a Sendai virus mutant, F1-R, in epithelial MDCK cells. J Virol (1993) 1.04
Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus. J Virol (1996) 0.98
Entry and release of transmissible gastroenteritis coronavirus are restricted to apical surfaces of polarized epithelial cells. J Virol (1994) 0.90
Vesicular stomatitis virus glycoprotein does not determine the site of virus release in polarized epithelial cells. J Virol (2002) 0.88
Mumps Virus Is Released from the Apical Surface of Polarized Epithelial Cells, and the Release Is Facilitated by a Rab11-Mediated Transport System. J Virol (2015) 0.82
Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice. J Virol (2009) 0.82
Vesicular stomatitis virus enables gene transfer and transsynaptic tracing in a wide range of organisms. J Comp Neurol (2015) 0.80
Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin. Med Microbiol Immunol (2004) 0.79
Canine distemper virus matrix protein influences particle infectivity, particle composition, and envelope distribution in polarized epithelial cells and modulates virulence. J Virol (2011) 0.78
Polar release of pathogenic Old World hantaviruses from renal tubular epithelial cells. Virol J (2012) 0.77
Cell surface polarity in epithelia. Annu Rev Cell Biol (1985) 6.92
Asymmetric budding of viruses in epithelial monlayers: a model system for study of epithelial polarity. Proc Natl Acad Sci U S A (1978) 6.85
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85
The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis (1980) 4.61
Regulation of protein export from the endoplasmic reticulum. Annu Rev Cell Biol (1988) 4.53
Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell (1984) 4.24
Development of cell surface polarity in the epithelial Madin-Darby canine kidney (MDCK) cell line. EMBO J (1984) 3.43
Assembly of animal viruses at cellular membranes. Annu Rev Microbiol (1988) 2.99
Identification of two strains of MDCK cells which resemble separate nephron tubule segments. Biochim Biophys Acta (1981) 2.78
The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus. J Immunol (1982) 1.94
Membrane (M) protein of HVJ (Sendai virus): its role in virus assembly. Virology (1976) 1.81
The M protein of vesicular stomatitis virus associates specifically with the basolateral membranes of polarized epithelial cells independently of the G protein. J Cell Biol (1988) 1.75
Sendai virus. Adv Virus Res (1978) 1.51
Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs. Infect Immun (1983) 1.39
Structural domains and organizational conformation involved in the sorting and transport of influenza virus transmembrane proteins. Annu Rev Microbiol (1989) 1.25
Type I collagen gel induces Madin-Darby canine kidney cells to become fusiform in shape and lose apical-basal polarity. J Cell Biol (1989) 1.19
Characterization of a pantropic variant of Sendai virus derived from a host range mutant. Virology (1988) 1.15
Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium. J Virol (1990) 1.14
Evidence of proteolytic activation of Sendai virus in mouse lung. Arch Virol (1983) 1.14
Nucleotide sequence analyses of the genes encoding the HN, M, NP, P, and L proteins of two host range mutants of Sendai virus. Virology (1990) 1.04
Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus. Arch Virol (1986) 0.93
Comparison of protective effects of serum antibody on respiratory and systemic infection of Sendai virus in mice. Arch Virol (1989) 0.84
On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology (1978) 9.02
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology (1974) 6.53
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05
Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol (1975) 4.89
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85
Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell (1987) 4.34
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature (1992) 4.16
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A (2001) 3.43
The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology (1979) 3.25
Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Nature (1989) 3.10
Isolation and preliminary characterization of temperature-sensitive mutants of influenza virus. J Virol (1972) 3.09
Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science (2001) 3.08
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res (2000) 2.96
Functional significance of sialidose during influenza virus multiplication. Virology (1966) 2.94
Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells. J Virol (1976) 2.91
The molecular biology of influenza virus pathogenicity. Adv Virus Res (1988) 2.90
Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology (1972) 2.84
Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J (1995) 2.76
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
Influenza viruses cause hemolysis and fusion of cells. Virology (1981) 2.73
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science (1985) 2.57
Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology (1978) 2.51
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Molecular biology and evolution of filoviruses. Arch Virol Suppl (1993) 2.45
Further isolation and characterization of temperature-sensitive mutants of influenza virus. Virology (1975) 2.42
Interactions of Marburg virus nucleocapsid proteins. Virology (1998) 2.37
The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion. Virology (1970) 2.37
Correlation between RNA fragments of fowl plague virus and their corresponding gene functions. Virology (1976) 2.36
A point mutation in the A gamma-globin gene promoter in Greek hereditary persistence of fetal haemoglobin. Nature (1985) 2.33
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol (1996) 2.26
How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res (1998) 2.25
Replication of Borna disease virus in cell cultures. Med Microbiol Immunol (1980) 2.24
Pause on avian flu transmission research. Science (2012) 2.24
Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology (2000) 2.21
Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol (1994) 2.17
Identification of a common antigen of herpes simplex virus bovine herpes mammillitis virus, and B virus. J Virol (1978) 2.16
Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology (1981) 2.13
Inhibition of the multiplication of enveloped RNA-viruses by glucosamine and 2-deoxy-D-glucose. J Gen Virol (1972) 2.12
Glycosylation and oligomerization of the spike protein of Marburg virus. Virology (1991) 2.11
Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science (1983) 2.10
Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J Virol (1997) 2.09
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol (2000) 2.09
Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J (2000) 2.08
Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie (1994) 2.07
Association of influenza virus proteins with cytoplasmic fractions. Virology (1974) 2.00
Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology (1977) 2.00
Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J (1986) 1.98
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97
Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96
The resurgence of Shamonda virus, an African Simbu group virus of the genus Orthobunyavirus, in Japan. Arch Virol (2004) 1.96
Synthesis in vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics. Virology (1970) 1.95
Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem (1986) 1.92
Infection and activation of monocytes by Marburg and Ebola viruses. J Virol (2001) 1.90
Molecular basis of infectivity and pathogenicity of myxovirus. Brief review. Arch Virol (1979) 1.89
Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses. Med Microbiol Immunol (1975) 1.89
An electron microscopic study of the presence or absence of neuraminic acid in enveloped viruses. Virology (1970) 1.88
The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Arch Virol Suppl (1999) 1.87
Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J Virol (1993) 1.85
Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol (1998) 1.85
Biosynthesis and role of filoviral glycoproteins. J Gen Virol (2001) 1.84
Generation of seal influenza virus variants pathogenic for chickens, because of hemagglutinin cleavage site changes. J Virol (1990) 1.81
Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology (1989) 1.81
Inhibition of glycosylation of the influenza virus hemagglutinin. J Virol (1974) 1.81
Marburg and Ebola viruses. Adv Virus Res (1996) 1.81
Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J Cell Biol (1994) 1.80
Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology (1992) 1.79
Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J Virol (2000) 1.79
Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus. J Mol Biol (2000) 1.79
The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J (1985) 1.76
The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol (1995) 1.76
Homologous interference mediated by defective interfering influenza virus derived from a temperature-sensitive mutant of influenza virus. J Virol (1978) 1.73